Outcomes of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort

This study revealed the feasibility and outcome of front-line pembrolizumab treatment in this population with BM.PMID:38534959 | PMC:PMC10969391 | DOI:10.3390/curroncol31030126

Source: Current Oncology - March 27, 2024 Category: Cancer & Oncology Authors: Simon Nannini Florian Guisier Hubert Curcio Charles Ricordel Pierre Demontrond Safa Abdallahoui Seyyid Baloglu Laurent Greillier Christos Chouaid Roland Schott Source Type: research